Isolated Gut Microbe Drives Stronger Responses to Cancer Therapy

Isolated gut microbe drives stronger responses to cancer therapy

The National Cancer Center Research Institute in Tokyo reports that a newly isolated gut bacterium, designated Hominenteromicrobium strain YB328, mobilizes specialized dendritic cells to strengthen the impact of PD-1 blockade immunotherapy across several tumor types.

Japanese scientists have discovered intestinal bacteria that increase the effectiveness of cancer drugs: how they work - Global Happenings

A group of researchers from Japan found that a certain strain of intestinal bacteria increases the efficiency of cancer immunotherapy. This showed an experiment using mice. Researchers from the National Oncological Center of Japan and other organizations published their conclusions in the scientific journal Nature. Scientists analyzed the feces of 50 patients with cancer who were undergoing immunotherapy. Patients who responded well to therapy w…

Genomic Study Uncovers Diverse Carbohydrate Use in Bifidobacteria

In a groundbreaking study published in Nature Microbiology, an international team of researchers led by Arzamasov, Rodionov, and Hibberd has unveiled unprecedented insights into the genetic and functional diversity of carbohydrate metabolism among human gut bifidobacteria. This research leverages cutting-edge integrative genomic reconstruction methodologies to dissect the heterogeneous strategies these prominent gut microbes employ to utilize di…

Beyond diversity: Research links functional microbial signatures with obesity

A new functional microbiota index has shown promise for identifying gut bacteria that may be linked to obesity.

Marinova to drill down fucoidan’s gut, immune, anti-inflammatory benefits

Australia firm Marinova is driving research on fucoidan’s potential benefits in gut, immune health, and anti-inflammatory effects.